{"disease":{"id":"pediatric-acute-leukemia","name":"pediatric acute leukemia"},"drugs":{"marketed":[{"drug_id":"daunorubicin-hydrochloride","indication_name":"Remission induction in pediatric and adult acute lymphocytic leukemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DAUNORUBICIN HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07150676","title":"Harmonized Clinical and Biological Database for Integrated Research Into the Management of Pediatric Acute Myeloid Leukemia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06184009","title":"Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":370,"lead_sponsor_name":"Jae Wook Lee","has_results":false},{"nct_id":"NCT07278882","title":"Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT05334823","title":"A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Chongqing Precision Biotech Co., Ltd","has_results":false},{"nct_id":"NCT07374315","title":"Weight Gain in Pediatric Leukemia Survivors","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT06158828","title":"Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":68,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05455268","title":"Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma Parents","phase":"NA","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Universiti Kebangsaan Malaysia Medical Centre","has_results":false},{"nct_id":"NCT05809284","title":"Determining the Mechanisms of Loss of CAR T Cell Persistence","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT03176849","title":"A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Phoenix Children's Hospital","has_results":false},{"nct_id":"NCT06508775","title":"Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Miltenyi Biomedicine GmbH","has_results":false},{"nct_id":"NCT07052994","title":"A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":32,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT01991249","title":"Targeted High Throughput Sequencing in the Diagnosis of Pediatric Acute Leukemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT01177540","title":"Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Eisai Inc.","has_results":true},{"nct_id":"NCT05866887","title":"Insomnia Prevention in Children With Acute Lymphoblastic Leukemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":true},{"nct_id":"NCT06421155","title":"Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia","phase":"NA","overall_status":"SUSPENDED","enrollment_count":20,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT04678336","title":"CD123 Redirected T Cells for AML in Pediatric Subjects","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03705507","title":"International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"University of Birmingham","has_results":false},{"nct_id":"NCT04501614","title":"A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT07437170","title":"Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT04888468","title":"Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Chongqing Precision Biotech Co., Ltd","has_results":false},{"nct_id":"NCT00439296","title":"ABT-751 With Chemotherapy for Relapsed Pediatric ALL","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Therapeutic Advances in Childhood Leukemia Consortium","has_results":true},{"nct_id":"NCT04049383","title":"CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT04996160","title":"Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Tanja Andrea Gruber","has_results":false},{"nct_id":"NCT04325841","title":"Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Beijing Boren Hospital","has_results":false},{"nct_id":"NCT04562792","title":"Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"Children's Mercy Hospital Kansas City","has_results":true}],"total":25},"guidelines":[],"source":"Drug Landscape verified database"}